SLRX

Salarius Pharmaceuticals, Inc. - Common Stock (SLRX)

About Salarius Pharmaceuticals, Inc. - Common Stock (SLRX)

Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. The company was founded in February 2014 and is headquartered in Houston, TX.

Details

Daily high

$0.84

Daily low

$0.72

Price at open

$0.78

52 Week High

$108.00

52 Week Low

$0.71

Market cap

4.6M

Dividend yield

0.00%

Volume

27,535

Avg. volume

532,428

P/E ratio

-.02

Salarius Pharmaceuticals, Inc. - Common Stock News